Bulletin of Experimental Biology and Medicine

, Volume 135, Supplement 7, pp 171–175

Comparative Efficiency of Proproten-100 during the Therapy of Patients with Alcoholism in the Stage of Therapeutic Remission

  • N. A. Bokhan
  • A. F. Abolonin
  • E. N. Krylov
  • T. P. Vetlugina
  • S. A. Ivanova
Article

DOI: 10.1023/A:1024709014483

Cite this article as:
Bokhan, N.A., Abolonin, A.F., Krylov, E.N. et al. Bulletin of Experimental Biology and Medicine (2003) 135: 171. doi:10.1023/A:1024709014483

Abstract

An open comparative clinical study evaluated the efficiency of Proproten-100 in reliving affective, somatovegetative, behavioral, and cognitive post-withdrawal disorders and manifestations of primary pathological alcohol addiction in patients with alcohol dependence in the stage of therapeutic remission. We compared the efficiency of Proproten-100 and standard symptomatic drugs. The preparation possessed anxiolytic, antidepressant, and vegetostabilizing properties, produced a moderate soporific effect, and had no sedative activity in patients with dysphoric depressions and psychopathic disorders. Proproten-100 was more effective during the therapy of patients with anxious and wistful depressions. Proproten-100 increased the contents of IgG and natural antibodies against S100 protein in the blood from patients. The preparation did not cause side effect or development of tolerance. Proproten-100 has psychotropic properties and holds much promise for long-term treatment of patients with alcohol dependence to reduce the incidence of recurrences.

alcohol dependenceProproten-100antidepressant activityanxiolytic activityantibodies against S100 protein

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • N. A. Bokhan
    • 1
  • A. F. Abolonin
    • 1
  • E. N. Krylov
    • 1
  • T. P. Vetlugina
    • 1
  • S. A. Ivanova
    • 1
  1. 1.Tomsk Research Center, Siberian Division of the Russian Academy of Medical SciencesInstitute of Mental HealthRussia